side effects of semaglutide shots FDA crackdown on off-brand Ozempic products set to take effect, threatening supply and access for many Diabetes advocacy group discourages use

Epigenetic alterations in immune cells of systemic Lupus erythematosus and therapeutic implications

[5] [6] Early-phase clinical trials including a Phase 2 trial published in the New England Journal of Medicine (2023) have reported significant reductions in body weight and improvements in metabolic markers, though this evidence remains preliminary and is not sufficient to establish a clinical dosing or reconstitution standard

Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis

Science 363 , 582583 (2019)

doi: 10.1016/j.micres.2025.128384

Each patent potentially qualified for its own PTE or contributed to a barrier requiring generic manufacturers to either design around or litigate